Paramount Comms Q2: consolidated PAT +83% YoY to ₹24.2 Cr as margins expand
PAT +82.94% YoY · revenue +30.93% · margins expanding
₹560.4 Cr
+30.93% YoY
₹24.24 Cr
+82.94% YoY
4.3%
+1.3pp YoY
₹0.74
Paramount Communications' consolidated Q2 FY27 (quarter ended 30.09.2026) revenue rose 30.9% YoY to ₹560.40 Cr (+5.9% QoQ from ₹529.40 Cr), while PAT jumped 82.9% YoY to ₹24.24 Cr (+23.1% QoQ from ₹19.70 Cr) and basic EPS rose to ₹0.74 from ₹0.43 a year ago. Standalone PAT was effectively identical at ₹24.24 Cr, so the consolidated print is not distorted by subsidiary contribution this quarter.
Q2 FY-2027 vs prior quarters
The margin story is the bigger shift: EBITDA margin (PBT + finance cost + depreciation, on revenue) expanded to ~7.98% this quarter from ~6.04% a year ago and ~7.15% last quarter. The driver is operating leverage on the cost line rather than raw materials — other expenses fell to 15.87% of revenue from 23.19% YoY (flat versus Q1FY27's 15.81%, so the bulk of the gain had already shown up by Q1 and simply held into Q2), while material costs stayed roughly steady as a share of revenue. That margin gain was partly offset below the line by finance costs nearly doubling YoY to ₹7.89 Cr (from ₹4.11 Cr) as borrowings rose to fund capacity expansion; PAT still outran PBT growth on a ₹1.20 Cr deferred-tax credit.
The stock went into the print at ₹60.75, down 2.5% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records.
What the summary numbers don't show
Standalone and consolidated results are virtually identical this quarter — year-ago consolidated figures included now-divested Valens Technologies (sold 06.11.2025), per company note, so the YoY consolidated comparison isn't fully like-for-like
FY27 revenue growth of 15-20%; EBITDA margins expected to reach FY25 levels (~8%) by Q4 FY27. Narmadapuram plant to contribute ₹500 Cr in FY28, scaling to ₹1,200 Cr by FY29. US exports targeted at ₹700-800 Cr for FY27, up from ₹155 Cr in Q1.
— This quarter: beat
No street/consensus estimates for this specific quarter turned up in search — Paramount is a small-cap wires-and-cables name without visible broker Q2 FY27 previews, so vsStreet is unknown rather than inferred. Against the company's own Q1 FY27 concall guidance (FY27 revenue growth of 15-20%, EBITDA margins toward ~8% FY25 levels by Q4 FY27), the print is running ahead: H1 FY27 consolidated revenue grew 23.97% YoY (₹1,089.80 Cr vs ₹879.12 Cr), already above the top of the full-year range, and the ~7.98% EBITDA margin this quarter is effectively at the ~8% target two quarters before the Q4 FY27 checkpoint management set. No company press release accompanied this filing, so the framing here rests on the numbers rather than management commentary. During the quarter the company also completed a ₹97.67 Cr capital raise via preferential equity shares and convertible warrants (₹92.39 Cr and ₹7.56 Cr respectively), of which ₹73.39 Cr has been utilised and ₹26.66 Cr remains parked in mutual funds — consistent with funding the ongoing capacity build-out (H1 PP&E additions of ₹41.30 Cr vs ₹25.01 Cr a year ago) rather than distress borrowing.
W1
EBITDA margin trajectory toward management's ~8% FY25-level target guided for Q4 FY27 — already at ~7.98% in Q2; watch whether Q3/Q4 hold this pace or compress as capex-related finance costs build
W2
Narmadapuram plant guided to contribute ₹500 Cr in FY28, scaling to ₹1,200 Cr by FY29 — H1FY27 PP&E additions of ₹41.30 Cr signal ramp-up; watch for capitalisation timeline and first revenue contribution
W3
US exports targeted at ₹700-800 Cr for FY27 (up from ₹155 Cr in Q1) — this filing discloses no segment-level export figures, so progress is unverified; watch for numbers or commentary at Q3
No exceptional items this quarter or year-ago quarter. Standalone and consolidated are nearly identical (subsidiaries Paramount Holdings and AEI Power Cables immaterial); year-ago consolidated comparatives still included Valens Technologies (divested 06.11.2025, per filing note), so the YoY consolidated comparison is not fully like-for-like, though the effect looks negligible given standalone/consolidated proximity.
31% Growth That Management Won't Bank On — The Margin Ramp Is the Real Story
Paramount delivered a 31% revenue pop and 83% PAT growth, but refused to raise full-year guidance. The call explains why — and reveals a company executing on margins rather than chasing top-line surprises.
₹560.4 Cr
+31% YoY, +5.9% QoQ
₹24.2 Cr
+83% YoY, +23% QoQ
7.3%
+67 bp QoQ, +170 bp YoY
15–20% growth
Not raised despite 31% Q2 print
On the surface, Paramount's Q2 looks like a blowout: 31% revenue growth and PAT up 83% year-on-year. But management did something unusual when it closed the earnings call — it didn't raise full-year guidance. Instead, it reaffirmed 15–20% FY27 growth, the same range from the prior quarter. That gap between the headline pop and the stubborn guidance is the story of the quarter.
Why the growth is outpacing guidance
The 31% revenue growth is real and sustainable, but it's not all organic. Q2 benefited from tariff normalization — the US IEPA tariffs were shut down by the US Supreme Court in February 2026, restoring customer confidence in export orders after months of uncertainty. Domestic business also held firm. But that tariff wind is a one-time tailwind, not a permanent shift in the FY27 run-rate. Management knows this, and it's being disciplined: the 15–20% FY27 guidance assumes the elevated growth base normalizes slightly as the year matures. That's credible execution discipline, not a miss.
The real story: margin recovery is on the glide path
The 7.3% operating margin in Q2 is the true signal of the quarter. This is a +67 basis point jump quarter-on-quarter from Q1's 6.6%, and it confirms management's guided trajectory towards 8% by Q4 FY27 (matching FY25's baseline). That glide path—6.6% (Q1) → 7.3% (Q2) → 8% (Q4)—is credible because it's supported by two real drivers: tariff normalization (allowing fixed costs to be spread over higher export volumes) and favorable metal pricing (aluminum showing softness, which is >75% of metal value in Paramount's mix).
The HTLS order book is impressive but unproven
Management announced a ₹200 crore HTLS (High Temperature Low Sag) order book during the call, a new-to-world product for Paramount. HTLS is a specialized conductor used in power transmission, and the national grid modernization plan projects ₹5 lakh crore in EHV transmission investment between 2027 and 2032 — a huge market. But here's the catch: Paramount reported zero revenue from HTLS in Q2. The orders are there, but execution is in the future. HTLS involves longer delivery cycles due to EPC (engineering, procurement, construction) work, and management guided that orders won't convert to revenue for several months. This is execution risk that will take time to validate. The order book is real, but scaling it will define the next two quarters.
Export guidance looks tight versus the run-rate
Management guided ₹700–800 crore in US exports for FY27. But H1 (first half) exports ran at ₹313 crore, which annualizes to roughly ₹626 crore—about 11% below the midpoint of guidance. Management capped exports at ~30% of revenue going forward, citing concentration risk and the desire to diversify back to Asia, Europe, and Oceania. That's a sensible risk-management call, but it also signals that the ₹700–800 crore guidance may require acceleration in H2 or a higher FY27 revenue base than the 15–20% guidance implies. It's a yellow flag, not a red one — the order book is strong at ₹731 crore — but watch this one.
The market has priced in deep skepticism
The stock is trading at ₹60.89, down 47.89% from its all-time high of ₹116.85. That's a jarring discount given that Paramount just delivered on its guided margin trajectory, has a ₹731 crore order book, and announced a ₹200 crore HTLS pipeline. The technical backdrop is mixed: RSI of 50 suggests neutral momentum, but volume is increasing, which hints at accumulation. Most tellingly, domestic institutional investors (DII) added 4 percentage points in Q2, while FII holdings remained flat at 0.45%. That's consistent with smart money quietly building positions ahead of the Narmadapuram ramp-up (partial commissioning expected Q1 FY28). The stock is not cheap relative to fair value, but the drawdown has created a window for patient capital.
Management's claims vs. what holds up
7.3% OPM in Q2 validates glide path to 8% by Q4
₹40.9 Cr operating profit / ₹560.4 Cr revenue = 7.3% ✓; margin expanded 67 bp QoQ and 170 bp YoY
Supported
31% revenue growth driven by domestic + export normalization
Domestic ₹402.3 Cr (71.8%), exports ₹158.1 Cr (28.2%); both segments growing; tariff headwinds eased
Supported
Order book ₹731 Cr is firm with minimal cancellation risk
Only firm orders in book; cancellations rare even in worst-case tariff scenarios; order quality high
Supported
HTLS ₹200 Cr order book will drive margin accretion
₹200 Cr order book confirmed; Q2 revenue impact zero; longer EPC cycles; execution unproven
Partial (credible intent, execution pending)
Narmadapuram ₹500 Cr FY28 target is on track
Foundation & civil works underway; partial Q1 FY28 commissioning confirmed; timeline unchanged; market absorption unproven
Partial (timeline credible, revenue risk high)
What changed on this call
Margin trajectory reaffirmed (6.6% → 7.3% → 8% by Q4)
Narmadapuram timeline unchanged: partial Q1 FY28 commissioning, ₹500 Cr FY28, ₹1,200 Cr FY29
Export guidance capped at ~30% of revenue; diversifying to Asia, Europe, Oceania
HTLS order book announced (₹200 Cr); data center cable approvals in progress
5-year revenue target (₹5,000 Cr by FY31) reaffirmed, not accelerated to 3 years
Bull and bear cases
Margin recovery on track: 6.6% → 7.3% → 8% trajectory is credible and supported by tariff normalization + metal pricing tailwinds
Order book strong at ₹731 Cr (3–4 month execution horizon); no major cancellations even in tariff crisis
Narmadapuram greenfield on schedule; doubling capacity to ~60,000 MT by FY29 addresses long-term growth
HTLS order book (₹200 Cr) targets ₹50,000+ Cr reconduct market; high-margin opportunity if execution proves out
DII accumulation (FII flat) and increasing volume suggest smart money building before Narmadapuram ramp
HTLS is nascent: zero Q2 revenue despite ₹200 Cr order book; longer EPC cycles and 220 kV approvals (1–1.5 years) create execution risk
Export guidance (₹700–800 Cr FY27) looks tight: H1 run-rate (₹313 Cr) annualizes to ~₹626 Cr, 11% below midpoint
Narmadapuram FY28 target (₹500 Cr) dependent on market absorption and product mix; approval timelines uncertain
Risks, ranked by holder concern
HTLS execution unproven: nascent product with longer EPC cycles; ₹200 Cr order book but zero Q2 revenue
MediumHTLS is critical to Narmadapuram's margin accretion story. If execution slips or customer demand softens, the ₹500 Cr FY28 target becomes at risk.
Export guidance tightness: H1 run-rate (₹313 Cr) annualizes to ~₹626 Cr vs ₹700–800 Cr guidance
MediumImplies either slower H2 export ramp-up or lower FY27 total revenue. Management capped exports at 30% to reduce US concentration risk, which is prudent but limits upside.
Narmadapuram ramp execution: ₹500 Cr FY28 dependent on market absorption and product mix
Medium220 kV approvals take 1–1.5 years; plant can start with 11/33/66 kV. If demand softens or approvals delay, the revenue ramp flattens.
US tariff re-escalation: exports at 28% of Q2 revenue; recent normalization (Feb 2026) could reverse
MediumRecent IEPA court ruling stabilized the tariff environment, but geopolitical risk remains. A re-escalation would hit export margins and delay diversification efforts.
Metal price volatility: copper and aluminum are >75% of metal cost
LowCompany hedges via 3–4 month firm-order policy; most customer orders carry tariff clauses. Mitigated but not eliminated.
The debate
1 · Q3 FY27 margin progression
The glide-path target is 8% by Q4. Q3 needs to show continued momentum. If margin contracts, the entire guidance narrative breaks.
2 · HTLS revenue visibility
Any HTLS revenue in Q3 or Q4 FY27 will validate the order book and executive confidence. Zero revenue through FY27 end would be a red flag for execution.
3 · Narmadapuram commissioning timeline
Foundation and civil work are on track. Partial Q1 FY28 commissioning is the next key milestone. Any slippage here derails the ₹500 Cr FY28 target.
Paramount is a steady-execution story, not a surprise-to-the-upside one. The margin recovery is credible, the order book is strong, and the long-term vision (Narmadapuram + HTLS + data center cables) is ambitious. But execution risks are real: HTLS is unproven, export guidance is tight, and Narmadapuram ramp assumptions are forward-looking. Management knows this, and it's being disciplined — reaffirming guidance despite a 31% revenue pop shows that. The stock has priced in skepticism at a 47% discount from ATH, and DII accumulation suggests smart money is building for the Narmadapuram story. For holders, the next 12–18 months will determine whether the margin glide-path holds and HTLS/Narmadapuram begin to contribute. For new buyers, the window is open — but only if you're willing to take on execution risk and wait. The single number to track from here is Q4 FY27 operating margin: if that clears 8% as guided, the credibility of the entire growth narrative stands.